1800 202 8726
Fertility after targeted therapy

How Long Must You Wait — Before Trying to Conceive?

Wanting a child after cancer treatment is a real and legitimate hope. The answer depends on which targeted therapy you took — but for most agents, ASCO and ESMO recommend a minimum waiting period before attempting conception. Knowing the timeline early helps you plan.

Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed August 2026

  • At least 6 months for most agents — ASCO and ESMO guidance sets this as the minimum interval after stopping most targeted therapies before trying to conceive.
  • The drug sets the clock, not the diagnosis — Washout periods depend on how long a specific agent stays active in the body — your oncologist can give you the figure for your drug.
  • Fertility preservation works best before treatment starts — If you have not yet begun targeted therapy and want children, tell your oncology team at the first appointment.
  • The wait applies to men as well as women — Sperm produced during or shortly after targeted therapy may carry effects from the drug. Both partners should discuss timing with their team.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Talk to a medical oncologist

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Reviewed by a senior medical oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

ASCO and ESMO guidance recommends waiting at least 6 months after stopping most targeted therapies before trying to conceive. The exact period depends on which drug you took and how long it remains active in the body. If you have not yet started treatment and want children, tell your oncologist before your first dose.

Why does targeted therapy require a waiting period before conception?

Targeted therapy drugs work by interfering with specific proteins that cancer cells use to grow. Many of those same proteins are active during embryo development. That overlap is why exposure during early pregnancy can cause harm to a developing baby.

Most targeted agents have shown harm in animal studies. Human pregnancy data is limited because clinical trials exclude pregnant patients. Because the risk cannot be measured precisely, ASCO and ESMO treat all targeted agents as potentially harmful to a developing pregnancy.

The washout period is the time your body needs to clear the drug after you stop taking it. For most targeted therapies, ASCO and ESMO recommend at least 6 months as the minimum interval before attempting conception.

Does the waiting time differ depending on which targeted therapy you had?

Drug categoryCommon cancers treatedWashout guidanceEvidence basis
Tyrosine kinase inhibitors (TKIs)Lung, CML, thyroid, kidneyAt least 6 months (ASCO, ESMO)Animal teratogenicity data; limited human data
PARP inhibitorsOvarian, breast, prostateAt least 6 months (ESMO)Animal embryotoxicity; human data still emerging
CDK4/6 inhibitorsBreast cancerAt least 6 months; guidance evolvingLimited human pregnancy data available
Anti-VEGF / angiogenesis inhibitorsColorectal, renal, liverAt least 6 months (ESMO)VEGF pathway essential for placental formation
mTOR inhibitorsRenal, neuroendocrineAt least 6 months (ESMO)Animal embryotoxicity; limited human data

Not sure what this means for you?

Share your reports and a senior oncologist will explain your options in plain language — no obligation to start treatment.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

You do not have to work this out alone

A 45-minute consultation with a specialist who treats this every week.

Book Free Consultation Call 1800 202 8726

Did you know?

Fertility preservation is most likely to succeed when it starts before your first dose of targeted therapy. Once treatment begins, some options are no longer available.

ASCO guidance states that every oncologist should discuss fertility with patients of reproductive age at the time of diagnosis — not after treatment has started.

Source: ASCO Clinical Practice Guideline: Fertility Preservation in Patients with Cancer

What else do families ask about timing and conception?

What exactly is a washout period, and how is it calculated?

A washout period is the time it takes for a drug to clear from your body after you stop taking it. It is based on the drug's half-life — the time it takes for half the remaining dose to leave your system. For most targeted agents, the drug itself clears within days, but the recommended 6-month interval adds a margin of safety for any lingering effects on egg or sperm quality, and for the critical window of embryo implantation and early organ formation.

Does the 6-month wait apply to men as well as women?

Yes. Sperm are produced continuously, and cells produced during targeted therapy exposure may carry drug-related effects. ASCO guidance recommends that men use effective contraception during treatment and for a period afterwards before attempting to father a pregnancy. The specific interval depends on the drug and should be confirmed with your oncologist. Men who want to preserve fertility should consider banking sperm before treatment begins — this is the most reliable option available.

What if you want to freeze eggs or embryos before starting treatment?

If you have not yet started treatment, this is the best time to discuss fertility preservation. Egg or embryo freezing requires a short stimulation cycle before the eggs are retrieved, and your oncologist and a fertility specialist can coordinate so that preservation is completed before your first dose. Tell your oncology team that fertility matters to you at the very first appointment — this changes the sequence of care and opens options that close once treatment begins.

Is it safe to try to conceive during targeted therapy?

No. Targeted therapy is not considered safe during an active pregnancy. Most agents carry animal data showing developmental harm, and ASCO and ESMO advise against conception during treatment. Highly effective contraception is recommended for all patients of reproductive age throughout the course of treatment. If you become pregnant during targeted therapy, contact your oncology team urgently — the situation requires specialist assessment and is different from the planned pregnancy this page describes.

Does the waiting period change if you plan to use IVF?

The washout period applies whether conception is natural or through IVF. IVF does not bypass the risks that drug exposure poses to egg quality, embryo development, or early placentation. If you froze eggs or embryos before treatment, your fertility specialist will advise when using them is appropriate in relation to your washout — and that timing should be confirmed with your oncologist before any cycle begins. Do not start a fertility treatment cycle before your oncologist confirms the washout is complete.

What if the cancer returns before the waiting period is over?

If treatment needs to restart before the washout is complete, conception should not be attempted. Your oncology team and your fertility specialist will discuss what this means for your plans — including whether previously frozen material can be held for longer, and whether a future treatment plan might allow a gap. This is a conversation worth having before it becomes urgent, ideally while you are in remission and the timing feels less pressured.

Explore 113 more Family, Fertility, Diet & Emotional Wellbeing topics

All Family, Fertility, Diet & Emotional Wellbeing →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Does the 6-month wait apply equally to all targeted drugs?

The 6-month figure is the minimum ASCO and ESMO recommend for most targeted agents, but the interval for your specific drug may differ. Some drugs have longer half-lives or have raised more concern in animal studies, and your oncologist may advise waiting longer. Ask specifically about the drug you took, not the category — and get the answer in writing so there is no ambiguity when you see your fertility specialist.

What contraception is recommended during targeted therapy?

ASCO and ESMO recommend highly effective contraception throughout targeted therapy for all patients of reproductive age. The appropriate method depends on your specific drug, because some hormonal contraceptives interact with targeted agents. Ask your oncologist which methods are safe for your treatment — a general answer is less useful than the one specific to your drug.

Can targeted therapy permanently affect fertility?

Some targeted therapies reduce ovarian reserve or affect sperm quality while others do not. The risk depends on which drug you took, for how long, and at what dose. The only way to know where you stand is a fertility assessment after the washout period ends. A fertility specialist can measure ovarian reserve or sperm quality and give you a realistic picture before you begin trying.

Should we tell the fertility clinic about the cancer treatment?

Yes, and in full detail. The fertility team needs to know which targeted agent you took, when you started and stopped, and your oncologist's view of the washout period. Some fertility clinics have limited experience with post-oncology patients. Ask whether the clinic has an oncofertility programme or works regularly with oncology teams, and bring a copy of your treatment summary to the first appointment.

Is it safe to breastfeed after targeted therapy?

Most targeted therapies are not considered safe during breastfeeding, and many are excreted in breast milk. ASCO and ESMO advise against breastfeeding for patients still within the washout period or who need to restart treatment. If your washout is complete, discuss it with both your oncologist and your obstetric team — the answer varies by drug and by how long ago treatment ended.

What does an oncofertility specialist do that an oncologist cannot?

An oncofertility specialist is a fertility doctor trained to work with cancer patients. They understand how different treatments affect egg and sperm quality, how to time a preservation cycle around an oncology schedule, and what realistic expectations look like after different agents. If you want to try for a pregnancy after targeted therapy, asking for a referral to an oncofertility programme — ideally before treatment starts — is worth pursuing.

Call now Book free consultation